BLCO Bausch + Lomb Corporation Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
20:35
Aug 24
Aug 24
Bausch and Lomb reports combined potential peak sales for both therapies exceed two billion.
Bausch and Lomb reports combined potential peak sales for both therapies exceed two billion dollars with phase two results for its ocular pain therapy expected in coming months.
20:35
Aug 24
Aug 24
Bausch + Lomb advances two eye health therapies based on trial results.
Bausch + Lomb advances two eye health therapies based on trial results, with one meeting its primary endpoint and another failing its primary endpoint but showing secondary benefits.
00:11
Jul 30
Jul 30
Reports Bausch + Lomb upgrading full-year outlook after strong quarter, no directional view.
LOW
23:17
Feb 27
Feb 27
"Since the ruling, more than a 100 companies have filed new lawsuits to try to get refunds here... Costco, FedEx, Dyson, Dollar General, Bausch and Lomb... They deserve a refund with interest, period, full stop." The Supreme Court struck down the tariff regime. The AG supports these companies' legal claims for refunds. If successful, these companies will receive significant one-time cash windfalls (refunds + interest) and see improved forward margins as tariff costs are removed from their COGS. LONG specific plaintiffs named in the lawsuits for potential cash windfalls. The administration may find a legal loophole to delay refunds or reinstate tariffs retroactively through a different mechanism.
00:31
Jan 14
Jan 14
Big healthcare companies may be undervalued.
After attending the JPMorgan Healthcare Conference, Cramer thinks large healthcare companies may all be undervalued and are well suited to a low inflation and low interest rate environment. He cites Cardinal Health, Amgen, Novartis, Bausch and Lomb, Eli Lilly, and Johnson & Johnson leadership.
HIGH
About BLCO Investor Commentary
Across the available history and selected sources, Buzzberg tracks BLCO (Bausch + Lomb Corporation) across 4 sources: 1 bullish vs 0 bearish calls from 4 authors. Historical directional balance: 20% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 5 total trade ideas tracked. Latest voices: FirstSquawk, BarbarianCap, Rob Bonta.